Sarepta Therapeutics (SRPT) AGM 2024 summary

Opening remarks and agenda

• The meeting was called to order at 10:00 A.M. EDT, with the Chairwoman presiding and the agenda outlined for attendees.

• Attendees included the full Board of Directors, executive committee members, and representatives from KPMG, the independent auditors.

• The agenda included voting on three proposals: election of directors, advisory vote on executive compensation, and ratification of auditors.

Board and executive committee updates

• Four individuals were nominated and stood for election as Class I Directors for a two-year term expiring at the 2026 AGM.

• The executive committee and key officers were introduced, highlighting leadership continuity.

Shareholder proposals

• Three proposals were presented: election of Class I Directors, advisory vote on named executive officer compensation, and ratification of KPMG as auditors for 2024.

• No additional proposals were introduced by stakeholders as per company bylaws.